Atypical antipsychotics in bipolar and schizoaffective disorders

Pharmacopsychiatry

Volumn 34, Issue 2, 2001, Pages 80-81

  Brown, E S ^a   Thomas, N R ^a   Carmody, T ^b   Mahadi, S ^a   Nejtek, V A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Academic Computing Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; EMERGENCY HEALTH SERVICE; FEMALE; HOSPITALIZATION; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; MEDICAL RECORD; PRIORITY JOURNAL; SCHIZOIDISM; SOCIAL PSYCHIATRY;

ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; EMERGENCY MEDICAL SERVICES; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RETROSPECTIVE STUDIES;

EID: 0035104762     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-15179     Document Type: Article

References (5)

1. Biological therapies chapter 33
2. Clozapine for treatment-refractory mania
3. Atypical antipsychotics. Part 1: Pharmacology, pharmacokinetics, and efficacy
4. Risperidone compared with both lithium and haloperidol in mania: A double-blind randomized controlled trial
5. Olanzapine versus placebo in the treatment of acute mania